Global Afoxolaner Chewable Tablets Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028
Meaning Afoxolaner's chewable tablets
The Afoxolaner Chewable Tablets market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 and Russia-Ukraine War influence, the global Afoxolaner Chewable Tablets market size was valued at USD million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period.
The Afoxolaner Chewable Tablets market in the USA. is estimated at USD million in 2022, which currently accounts for a % share in the global market. China, the world`s second largest economy, is estimated at USD million in 2022 and holds a % percent.
Tick Infection in Dogs occupied for % of the Afoxolaner Chewable Tablets global market in 2021, and it is projected to value USD million by 2028, growing at a % CAGR in next six years. In terms of product type, Afoxolaner Chewable Tablets segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Afoxolaner Chewable Tablets include Merial Toulouse and Boehringer Ingelheim.. etc. In terms of revenue, the global top four players hold a share over % in 2021.
Key Features of This Report:
This report provides in-depth analysis of the global Afoxolaner Chewable Tablets market, and provides market size (value, volume and average price) and CAGR for the history and forecast period (2017-2022, 2023-2028), considering 2021 as the base year
Main Afoxolaner Chewable Tablets manufacturers’ industry ranking, sales, revenue, price, and market share analysis. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This reports profiles key players in the global Afoxolaner Chewable Tablets market based on the following parameters – headquarters, production locations, products portfolio, Afoxolaner Chewable Tablets revenue, sales, average price and gross margin, recent developments.
Evaluation and forecast the Afoxolaner Chewable Tablets market size, projected growth trends, and corresponding market share analysis by type, by application, and by region. It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
Highlights of the current market scenario, recent information, latest developments, and factors impacting the growth of the market
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
Market Segmentation
Afoxolaner Chewable Tablets market is split by Purity and by Symptom. For the period 2017-2028, the growth among segments provides accurate calculations and forecasts for sales by Purity, and by Symptom in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Purity (2017-2028; USD Million)
Chapter 1, to describe Afoxolaner Chewable Tablets product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Afoxolaner Chewable Tablets, with price, sales, revenue and global market share of Afoxolaner Chewable Tablets from 2019 to 2022.
Chapter 3, the Afoxolaner Chewable Tablets competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Afoxolaner Chewable Tablets breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Purity and symptom, with sales market share and growth rate by purity, symptom, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Afoxolaner Chewable Tablets market forecast, by regions, purity and symptom, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Afoxolaner Chewable Tablets.
Chapter 13, 14, and 15, to describe Afoxolaner Chewable Tablets sales channel, distributors, customers, research findings and conclusion, appendix and data source.
The Afoxolaner Chewable Tablets market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 and Russia-Ukraine War influence, the global Afoxolaner Chewable Tablets market size was valued at USD million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period.
The Afoxolaner Chewable Tablets market in the USA. is estimated at USD million in 2022, which currently accounts for a % share in the global market. China, the world`s second largest economy, is estimated at USD million in 2022 and holds a % percent.
Tick Infection in Dogs occupied for % of the Afoxolaner Chewable Tablets global market in 2021, and it is projected to value USD million by 2028, growing at a % CAGR in next six years. In terms of product type, Afoxolaner Chewable Tablets segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Afoxolaner Chewable Tablets include Merial Toulouse and Boehringer Ingelheim.. etc. In terms of revenue, the global top four players hold a share over % in 2021.
Key Features of This Report:
This report provides in-depth analysis of the global Afoxolaner Chewable Tablets market, and provides market size (value, volume and average price) and CAGR for the history and forecast period (2017-2022, 2023-2028), considering 2021 as the base year
Main Afoxolaner Chewable Tablets manufacturers’ industry ranking, sales, revenue, price, and market share analysis. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This reports profiles key players in the global Afoxolaner Chewable Tablets market based on the following parameters – headquarters, production locations, products portfolio, Afoxolaner Chewable Tablets revenue, sales, average price and gross margin, recent developments.
Evaluation and forecast the Afoxolaner Chewable Tablets market size, projected growth trends, and corresponding market share analysis by type, by application, and by region. It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
Highlights of the current market scenario, recent information, latest developments, and factors impacting the growth of the market
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
Market Segmentation
Afoxolaner Chewable Tablets market is split by Purity and by Symptom. For the period 2017-2028, the growth among segments provides accurate calculations and forecasts for sales by Purity, and by Symptom in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Purity (2017-2028; USD Million)
- Afoxolaner Chewable Tablets
- Afoxolaner and Milbemycin Oxime Chewable Tablets
- Tick Infection in Dogs
- Gastrointestinal Nematode Infection in Dogs
- Other
- Merial Toulouse
- Boehringer Ingelheim
- North America (United States, Canada and Mexico)
- Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
- South America (Brazil, Argentina, Colombia, and Rest of South America)
- Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Chapter 1, to describe Afoxolaner Chewable Tablets product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Afoxolaner Chewable Tablets, with price, sales, revenue and global market share of Afoxolaner Chewable Tablets from 2019 to 2022.
Chapter 3, the Afoxolaner Chewable Tablets competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Afoxolaner Chewable Tablets breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Purity and symptom, with sales market share and growth rate by purity, symptom, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Afoxolaner Chewable Tablets market forecast, by regions, purity and symptom, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Afoxolaner Chewable Tablets.
Chapter 13, 14, and 15, to describe Afoxolaner Chewable Tablets sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 MARKET OVERVIEW
1.1 Afoxolaner Chewable Tablets Introduction
1.2 Market Analysis by Purity
1.2.1 Overview: Global Afoxolaner Chewable Tablets Revenue by Purity: 2017 Versus 2021 Versus 2028
1.2.2 Afoxolaner Chewable Tablets
1.2.3 Afoxolaner and Milbemycin Oxime Chewable Tablets
1.3 Market Analysis by Symptom
1.3.1 Overview: Global Afoxolaner Chewable Tablets Revenue by Symptom: 2017 Versus 2021 Versus 2028
1.3.2 Tick Infection in Dogs
1.3.3 Gastrointestinal Nematode Infection in Dogs
1.3.4 Other
1.4 Global Afoxolaner Chewable Tablets Market Size & Forecast
1.4.1 Global Afoxolaner Chewable Tablets Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Afoxolaner Chewable Tablets Sales in Volume (2017-2028)
1.4.3 Global Afoxolaner Chewable Tablets Price (2017-2028)
1.5 Global Afoxolaner Chewable Tablets Production Capacity Analysis
1.5.1 Global Afoxolaner Chewable Tablets Total Production Capacity (2017-2028)
1.5.2 Global Afoxolaner Chewable Tablets Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Afoxolaner Chewable Tablets Market Drivers
1.6.2 Afoxolaner Chewable Tablets Market Restraints
1.6.3 Afoxolaner Chewable Tablets Trends Analysis
2 MANUFACTURERS PROFILES
2.1 Merial Toulouse
2.1.1 Merial Toulouse Details
2.1.2 Merial Toulouse Major Business
2.1.3 Merial Toulouse Afoxolaner Chewable Tablets Product and Services
2.1.4 Merial Toulouse Afoxolaner Chewable Tablets Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Boehringer Ingelheim
2.2.1 Boehringer Ingelheim Details
2.2.2 Boehringer Ingelheim Major Business
2.2.3 Boehringer Ingelheim Afoxolaner Chewable Tablets Product and Services
2.2.4 Boehringer Ingelheim Afoxolaner Chewable Tablets Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 AFOXOLANER CHEWABLE TABLETS BREAKDOWN DATA BY MANUFACTURER
3.1 Global Afoxolaner Chewable Tablets Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Afoxolaner Chewable Tablets Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Afoxolaner Chewable Tablets
3.4 Market Concentration Rate
3.4.1 Top 3 Afoxolaner Chewable Tablets Manufacturer Market Share in 2021
3.4.2 Top 6 Afoxolaner Chewable Tablets Manufacturer Market Share in 2021
3.5 Global Afoxolaner Chewable Tablets Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Afoxolaner Chewable Tablets Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 MARKET ANALYSIS BY REGION
4.1 Global Afoxolaner Chewable Tablets Market Size by Region
4.1.1 Global Afoxolaner Chewable Tablets Sales in Volume by Region (2017-2028)
4.1.2 Global Afoxolaner Chewable Tablets Revenue by Region (2017-2028)
4.2 North America Afoxolaner Chewable Tablets Revenue (2017-2028)
4.3 Europe Afoxolaner Chewable Tablets Revenue (2017-2028)
4.4 Asia-Pacific Afoxolaner Chewable Tablets Revenue (2017-2028)
4.5 South America Afoxolaner Chewable Tablets Revenue (2017-2028)
4.6 Middle East and Africa Afoxolaner Chewable Tablets Revenue (2017-2028)
5 MARKET SEGMENT BY PURITY
5.1 Global Afoxolaner Chewable Tablets Sales in Volume by Purity (2017-2028)
5.2 Global Afoxolaner Chewable Tablets Revenue by Purity (2017-2028)
5.3 Global Afoxolaner Chewable Tablets Price by Purity (2017-2028)
6 MARKET SEGMENT BY SYMPTOM
6.1 Global Afoxolaner Chewable Tablets Sales in Volume by Symptom (2017-2028)
6.2 Global Afoxolaner Chewable Tablets Revenue by Symptom (2017-2028)
6.3 Global Afoxolaner Chewable Tablets Price by Symptom (2017-2028)
7 NORTH AMERICA BY COUNTRY, BY PURITY, AND BY SYMPTOM
7.1 North America Afoxolaner Chewable Tablets Sales by Purity (2017-2028)
7.2 North America Afoxolaner Chewable Tablets Sales by Symptom (2017-2028)
7.3 North America Afoxolaner Chewable Tablets Market Size by Country
7.3.1 North America Afoxolaner Chewable Tablets Sales in Volume by Country (2017-2028)
7.3.2 North America Afoxolaner Chewable Tablets Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 EUROPE BY COUNTRY, BY PURITY, AND BY SYMPTOM
8.1 Europe Afoxolaner Chewable Tablets Sales by Purity (2017-2028)
8.2 Europe Afoxolaner Chewable Tablets Sales by Symptom (2017-2028)
8.3 Europe Afoxolaner Chewable Tablets Market Size by Country
8.3.1 Europe Afoxolaner Chewable Tablets Sales in Volume by Country (2017-2028)
8.3.2 Europe Afoxolaner Chewable Tablets Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 ASIA-PACIFIC BY REGION, BY PURITY, AND BY SYMPTOM
9.1 Asia-Pacific Afoxolaner Chewable Tablets Sales by Purity (2017-2028)
9.2 Asia-Pacific Afoxolaner Chewable Tablets Sales by Symptom (2017-2028)
9.3 Asia-Pacific Afoxolaner Chewable Tablets Market Size by Region
9.3.1 Asia-Pacific Afoxolaner Chewable Tablets Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Afoxolaner Chewable Tablets Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 SOUTH AMERICA BY REGION, BY PURITY, AND BY SYMPTOM
10.1 South America Afoxolaner Chewable Tablets Sales by Purity (2017-2028)
10.2 South America Afoxolaner Chewable Tablets Sales by Symptom (2017-2028)
10.3 South America Afoxolaner Chewable Tablets Market Size by Country
10.3.1 South America Afoxolaner Chewable Tablets Sales in Volume by Country (2017-2028)
10.3.2 South America Afoxolaner Chewable Tablets Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 MIDDLE EAST & AFRICA BY COUNTRY, BY PURITY, AND BY SYMPTOM
11.1 Middle East & Africa Afoxolaner Chewable Tablets Sales by Purity (2017-2028)
11.2 Middle East & Africa Afoxolaner Chewable Tablets Sales by Symptom (2017-2028)
11.3 Middle East & Africa Afoxolaner Chewable Tablets Market Size by Country
11.3.1 Middle East & Africa Afoxolaner Chewable Tablets Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Afoxolaner Chewable Tablets Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 RAW MATERIAL AND INDUSTRY CHAIN
12.1 Raw Material of Afoxolaner Chewable Tablets and Key Manufacturers
12.2 Manufacturing Costs Percentage of Afoxolaner Chewable Tablets
12.3 Afoxolaner Chewable Tablets Production Process
12.4 Afoxolaner Chewable Tablets Industrial Chain
13 SALES CHANNEL, DISTRIBUTORS, TRADERS AND DEALERS
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Afoxolaner Chewable Tablets Typical Distributors
13.3 Afoxolaner Chewable Tablets Typical Customers
14 RESEARCH FINDINGS AND CONCLUSION
15 APPENDIX
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer
1.1 Afoxolaner Chewable Tablets Introduction
1.2 Market Analysis by Purity
1.2.1 Overview: Global Afoxolaner Chewable Tablets Revenue by Purity: 2017 Versus 2021 Versus 2028
1.2.2 Afoxolaner Chewable Tablets
1.2.3 Afoxolaner and Milbemycin Oxime Chewable Tablets
1.3 Market Analysis by Symptom
1.3.1 Overview: Global Afoxolaner Chewable Tablets Revenue by Symptom: 2017 Versus 2021 Versus 2028
1.3.2 Tick Infection in Dogs
1.3.3 Gastrointestinal Nematode Infection in Dogs
1.3.4 Other
1.4 Global Afoxolaner Chewable Tablets Market Size & Forecast
1.4.1 Global Afoxolaner Chewable Tablets Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Afoxolaner Chewable Tablets Sales in Volume (2017-2028)
1.4.3 Global Afoxolaner Chewable Tablets Price (2017-2028)
1.5 Global Afoxolaner Chewable Tablets Production Capacity Analysis
1.5.1 Global Afoxolaner Chewable Tablets Total Production Capacity (2017-2028)
1.5.2 Global Afoxolaner Chewable Tablets Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Afoxolaner Chewable Tablets Market Drivers
1.6.2 Afoxolaner Chewable Tablets Market Restraints
1.6.3 Afoxolaner Chewable Tablets Trends Analysis
2 MANUFACTURERS PROFILES
2.1 Merial Toulouse
2.1.1 Merial Toulouse Details
2.1.2 Merial Toulouse Major Business
2.1.3 Merial Toulouse Afoxolaner Chewable Tablets Product and Services
2.1.4 Merial Toulouse Afoxolaner Chewable Tablets Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Boehringer Ingelheim
2.2.1 Boehringer Ingelheim Details
2.2.2 Boehringer Ingelheim Major Business
2.2.3 Boehringer Ingelheim Afoxolaner Chewable Tablets Product and Services
2.2.4 Boehringer Ingelheim Afoxolaner Chewable Tablets Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 AFOXOLANER CHEWABLE TABLETS BREAKDOWN DATA BY MANUFACTURER
3.1 Global Afoxolaner Chewable Tablets Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Afoxolaner Chewable Tablets Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Afoxolaner Chewable Tablets
3.4 Market Concentration Rate
3.4.1 Top 3 Afoxolaner Chewable Tablets Manufacturer Market Share in 2021
3.4.2 Top 6 Afoxolaner Chewable Tablets Manufacturer Market Share in 2021
3.5 Global Afoxolaner Chewable Tablets Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Afoxolaner Chewable Tablets Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 MARKET ANALYSIS BY REGION
4.1 Global Afoxolaner Chewable Tablets Market Size by Region
4.1.1 Global Afoxolaner Chewable Tablets Sales in Volume by Region (2017-2028)
4.1.2 Global Afoxolaner Chewable Tablets Revenue by Region (2017-2028)
4.2 North America Afoxolaner Chewable Tablets Revenue (2017-2028)
4.3 Europe Afoxolaner Chewable Tablets Revenue (2017-2028)
4.4 Asia-Pacific Afoxolaner Chewable Tablets Revenue (2017-2028)
4.5 South America Afoxolaner Chewable Tablets Revenue (2017-2028)
4.6 Middle East and Africa Afoxolaner Chewable Tablets Revenue (2017-2028)
5 MARKET SEGMENT BY PURITY
5.1 Global Afoxolaner Chewable Tablets Sales in Volume by Purity (2017-2028)
5.2 Global Afoxolaner Chewable Tablets Revenue by Purity (2017-2028)
5.3 Global Afoxolaner Chewable Tablets Price by Purity (2017-2028)
6 MARKET SEGMENT BY SYMPTOM
6.1 Global Afoxolaner Chewable Tablets Sales in Volume by Symptom (2017-2028)
6.2 Global Afoxolaner Chewable Tablets Revenue by Symptom (2017-2028)
6.3 Global Afoxolaner Chewable Tablets Price by Symptom (2017-2028)
7 NORTH AMERICA BY COUNTRY, BY PURITY, AND BY SYMPTOM
7.1 North America Afoxolaner Chewable Tablets Sales by Purity (2017-2028)
7.2 North America Afoxolaner Chewable Tablets Sales by Symptom (2017-2028)
7.3 North America Afoxolaner Chewable Tablets Market Size by Country
7.3.1 North America Afoxolaner Chewable Tablets Sales in Volume by Country (2017-2028)
7.3.2 North America Afoxolaner Chewable Tablets Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 EUROPE BY COUNTRY, BY PURITY, AND BY SYMPTOM
8.1 Europe Afoxolaner Chewable Tablets Sales by Purity (2017-2028)
8.2 Europe Afoxolaner Chewable Tablets Sales by Symptom (2017-2028)
8.3 Europe Afoxolaner Chewable Tablets Market Size by Country
8.3.1 Europe Afoxolaner Chewable Tablets Sales in Volume by Country (2017-2028)
8.3.2 Europe Afoxolaner Chewable Tablets Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 ASIA-PACIFIC BY REGION, BY PURITY, AND BY SYMPTOM
9.1 Asia-Pacific Afoxolaner Chewable Tablets Sales by Purity (2017-2028)
9.2 Asia-Pacific Afoxolaner Chewable Tablets Sales by Symptom (2017-2028)
9.3 Asia-Pacific Afoxolaner Chewable Tablets Market Size by Region
9.3.1 Asia-Pacific Afoxolaner Chewable Tablets Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Afoxolaner Chewable Tablets Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 SOUTH AMERICA BY REGION, BY PURITY, AND BY SYMPTOM
10.1 South America Afoxolaner Chewable Tablets Sales by Purity (2017-2028)
10.2 South America Afoxolaner Chewable Tablets Sales by Symptom (2017-2028)
10.3 South America Afoxolaner Chewable Tablets Market Size by Country
10.3.1 South America Afoxolaner Chewable Tablets Sales in Volume by Country (2017-2028)
10.3.2 South America Afoxolaner Chewable Tablets Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 MIDDLE EAST & AFRICA BY COUNTRY, BY PURITY, AND BY SYMPTOM
11.1 Middle East & Africa Afoxolaner Chewable Tablets Sales by Purity (2017-2028)
11.2 Middle East & Africa Afoxolaner Chewable Tablets Sales by Symptom (2017-2028)
11.3 Middle East & Africa Afoxolaner Chewable Tablets Market Size by Country
11.3.1 Middle East & Africa Afoxolaner Chewable Tablets Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Afoxolaner Chewable Tablets Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 RAW MATERIAL AND INDUSTRY CHAIN
12.1 Raw Material of Afoxolaner Chewable Tablets and Key Manufacturers
12.2 Manufacturing Costs Percentage of Afoxolaner Chewable Tablets
12.3 Afoxolaner Chewable Tablets Production Process
12.4 Afoxolaner Chewable Tablets Industrial Chain
13 SALES CHANNEL, DISTRIBUTORS, TRADERS AND DEALERS
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Afoxolaner Chewable Tablets Typical Distributors
13.3 Afoxolaner Chewable Tablets Typical Customers
14 RESEARCH FINDINGS AND CONCLUSION
15 APPENDIX
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer
LIST OF TABLES
Table 1. Global Afoxolaner Chewable Tablets Revenue by Purity, (USD Million), 2017 & 2021 & 2028
Table 2. Global Afoxolaner Chewable Tablets Revenue by Symptom, (USD Million), 2017 & 2021 & 2028
Table 3. Merial Toulouse Basic Information, Manufacturing Base and Competitors
Table 4. Merial Toulouse Major Business
Table 5. Merial Toulouse Afoxolaner Chewable Tablets Product and Services
Table 6. Merial Toulouse Afoxolaner Chewable Tablets Sales (Box), Price (US$/Box), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors
Table 8. Boehringer Ingelheim Major Business
Table 9. Boehringer Ingelheim Afoxolaner Chewable Tablets Product and Services
Table 10. Boehringer Ingelheim Afoxolaner Chewable Tablets Sales (Box), Price (US$/Box), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Global Afoxolaner Chewable Tablets Sales by Manufacturer (2019, 2020, 2021, and 2022) & (Box)
Table 12. Global Afoxolaner Chewable Tablets Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 13. Market Position of Manufacturers in Afoxolaner Chewable Tablets, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 14. Global Afoxolaner Chewable Tablets Production Capacity by Company, (Box): 2020 VS 2021
Table 15. Head Office and Afoxolaner Chewable Tablets Production Site of Key Manufacturer
Table 16. Afoxolaner Chewable Tablets New Entrant and Capacity Expansion Plans
Table 17. Afoxolaner Chewable Tablets Mergers & Acquisitions in the Past Five Years
Table 18. Global Afoxolaner Chewable Tablets Sales by Region (2017-2022) & (Box)
Table 19. Global Afoxolaner Chewable Tablets Sales by Region (2023-2028) & (Box)
Table 20. Global Afoxolaner Chewable Tablets Revenue by Region (2017-2022) & (USD Million)
Table 21. Global Afoxolaner Chewable Tablets Revenue by Region (2023-2028) & (USD Million)
Table 22. Global Afoxolaner Chewable Tablets Sales by Purity (2017-2022) & (Box)
Table 23. Global Afoxolaner Chewable Tablets Sales by Purity (2023-2028) & (Box)
Table 24. Global Afoxolaner Chewable Tablets Revenue by Purity (2017-2022) & (USD Million)
Table 25. Global Afoxolaner Chewable Tablets Revenue by Purity (2023-2028) & (USD Million)
Table 26. Global Afoxolaner Chewable Tablets Price by Purity (2017-2022) & (US$/Box)
Table 27. Global Afoxolaner Chewable Tablets Price by Purity (2023-2028) & (US$/Box)
Table 28. Global Afoxolaner Chewable Tablets Sales by Symptom (2017-2022) & (Box)
Table 29. Global Afoxolaner Chewable Tablets Sales by Symptom (2023-2028) & (Box)
Table 30. Global Afoxolaner Chewable Tablets Revenue by Symptom (2017-2022) & (USD Million)
Table 31. Global Afoxolaner Chewable Tablets Revenue by Symptom (2023-2028) & (USD Million)
Table 32. Global Afoxolaner Chewable Tablets Price by Symptom (2017-2022) & (US$/Box)
Table 33. Global Afoxolaner Chewable Tablets Price by Symptom (2023-2028) & (US$/Box)
Table 34. North America Afoxolaner Chewable Tablets Sales by Country (2017-2022) & (Box)
Table 35. North America Afoxolaner Chewable Tablets Sales by Country (2023-2028) & (Box)
Table 36. North America Afoxolaner Chewable Tablets Revenue by Country (2017-2022) & (USD Million)
Table 37. North America Afoxolaner Chewable Tablets Revenue by Country (2023-2028) & (USD Million)
Table 38. North America Afoxolaner Chewable Tablets Sales by Purity (2017-2022) & (Box)
Table 39. North America Afoxolaner Chewable Tablets Sales by Purity (2023-2028) & (Box)
Table 40. North America Afoxolaner Chewable Tablets Sales by Symptom (2017-2022) & (Box)
Table 41. North America Afoxolaner Chewable Tablets Sales by Symptom (2023-2028) & (Box)
Table 42. Europe Afoxolaner Chewable Tablets Sales by Country (2017-2022) & (Box)
Table 43. Europe Afoxolaner Chewable Tablets Sales by Country (2023-2028) & (Box)
Table 44. Europe Afoxolaner Chewable Tablets Revenue by Country (2017-2022) & (USD Million)
Table 45. Europe Afoxolaner Chewable Tablets Revenue by Country (2023-2028) & (USD Million)
Table 46. Europe Afoxolaner Chewable Tablets Sales by Purity (2017-2022) & (Box)
Table 47. Europe Afoxolaner Chewable Tablets Sales by Purity (2023-2028) & (Box)
Table 48. Europe Afoxolaner Chewable Tablets Sales by Symptom (2017-2022) & (Box)
Table 49. Europe Afoxolaner Chewable Tablets Sales by Symptom (2023-2028) & (Box)
Table 50. Asia-Pacific Afoxolaner Chewable Tablets Sales by Region (2017-2022) & (Box)
Table 51. Asia-Pacific Afoxolaner Chewable Tablets Sales by Region (2023-2028) & (Box)
Table 52. Asia-Pacific Afoxolaner Chewable Tablets Revenue by Region (2017-2022) & (USD Million)
Table 53. Asia-Pacific Afoxolaner Chewable Tablets Revenue by Region (2023-2028) & (USD Million)
Table 54. Asia-Pacific Afoxolaner Chewable Tablets Sales by Purity (2017-2022) & (Box)
Table 55. Asia-Pacific Afoxolaner Chewable Tablets Sales by Purity (2023-2028) & (Box)
Table 56. Asia-Pacific Afoxolaner Chewable Tablets Sales by Symptom (2017-2022) & (Box)
Table 57. Asia-Pacific Afoxolaner Chewable Tablets Sales by Symptom (2023-2028) & (Box)
Table 58. South America Afoxolaner Chewable Tablets Sales by Country (2017-2022) & (Box)
Table 59. South America Afoxolaner Chewable Tablets Sales by Country (2023-2028) & (Box)
Table 60. South America Afoxolaner Chewable Tablets Revenue by Country (2017-2022) & (USD Million)
Table 61. South America Afoxolaner Chewable Tablets Revenue by Country (2023-2028) & (USD Million)
Table 62. South America Afoxolaner Chewable Tablets Sales by Purity (2017-2022) & (Box)
Table 63. South America Afoxolaner Chewable Tablets Sales by Purity (2023-2028) & (Box)
Table 64. South America Afoxolaner Chewable Tablets Sales by Symptom (2017-2022) & (Box)
Table 65. South America Afoxolaner Chewable Tablets Sales by Symptom (2023-2028) & (Box)
Table 66. Middle East & Africa Afoxolaner Chewable Tablets Sales by Region (2017-2022) & (Box)
Table 67. Middle East & Africa Afoxolaner Chewable Tablets Sales by Region (2023-2028) & (Box)
Table 68. Middle East & Africa Afoxolaner Chewable Tablets Revenue by Region (2017-2022) & (USD Million)
Table 69. Middle East & Africa Afoxolaner Chewable Tablets Revenue by Region (2023-2028) & (USD Million)
Table 70. Middle East & Africa Afoxolaner Chewable Tablets Sales by Purity (2017-2022) & (Box)
Table 71. Middle East & Africa Afoxolaner Chewable Tablets Sales by Purity (2023-2028) & (Box)
Table 72. Middle East & Africa Afoxolaner Chewable Tablets Sales by Symptom (2017-2022) & (Box)
Table 73. Middle East & Africa Afoxolaner Chewable Tablets Sales by Symptom (2023-2028) & (Box)
Table 74. Afoxolaner Chewable Tablets Raw Material
Table 75. Key Manufacturers of Afoxolaner Chewable Tablets Raw Materials
Table 76. Direct Channel Pros & Cons
Table 77. Indirect Channel Pros & Cons
Table 78. Afoxolaner Chewable Tablets Typical Distributors
Table 79. Afoxolaner Chewable Tablets Typical Customers
Table 1. Global Afoxolaner Chewable Tablets Revenue by Purity, (USD Million), 2017 & 2021 & 2028
Table 2. Global Afoxolaner Chewable Tablets Revenue by Symptom, (USD Million), 2017 & 2021 & 2028
Table 3. Merial Toulouse Basic Information, Manufacturing Base and Competitors
Table 4. Merial Toulouse Major Business
Table 5. Merial Toulouse Afoxolaner Chewable Tablets Product and Services
Table 6. Merial Toulouse Afoxolaner Chewable Tablets Sales (Box), Price (US$/Box), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors
Table 8. Boehringer Ingelheim Major Business
Table 9. Boehringer Ingelheim Afoxolaner Chewable Tablets Product and Services
Table 10. Boehringer Ingelheim Afoxolaner Chewable Tablets Sales (Box), Price (US$/Box), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Global Afoxolaner Chewable Tablets Sales by Manufacturer (2019, 2020, 2021, and 2022) & (Box)
Table 12. Global Afoxolaner Chewable Tablets Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 13. Market Position of Manufacturers in Afoxolaner Chewable Tablets, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 14. Global Afoxolaner Chewable Tablets Production Capacity by Company, (Box): 2020 VS 2021
Table 15. Head Office and Afoxolaner Chewable Tablets Production Site of Key Manufacturer
Table 16. Afoxolaner Chewable Tablets New Entrant and Capacity Expansion Plans
Table 17. Afoxolaner Chewable Tablets Mergers & Acquisitions in the Past Five Years
Table 18. Global Afoxolaner Chewable Tablets Sales by Region (2017-2022) & (Box)
Table 19. Global Afoxolaner Chewable Tablets Sales by Region (2023-2028) & (Box)
Table 20. Global Afoxolaner Chewable Tablets Revenue by Region (2017-2022) & (USD Million)
Table 21. Global Afoxolaner Chewable Tablets Revenue by Region (2023-2028) & (USD Million)
Table 22. Global Afoxolaner Chewable Tablets Sales by Purity (2017-2022) & (Box)
Table 23. Global Afoxolaner Chewable Tablets Sales by Purity (2023-2028) & (Box)
Table 24. Global Afoxolaner Chewable Tablets Revenue by Purity (2017-2022) & (USD Million)
Table 25. Global Afoxolaner Chewable Tablets Revenue by Purity (2023-2028) & (USD Million)
Table 26. Global Afoxolaner Chewable Tablets Price by Purity (2017-2022) & (US$/Box)
Table 27. Global Afoxolaner Chewable Tablets Price by Purity (2023-2028) & (US$/Box)
Table 28. Global Afoxolaner Chewable Tablets Sales by Symptom (2017-2022) & (Box)
Table 29. Global Afoxolaner Chewable Tablets Sales by Symptom (2023-2028) & (Box)
Table 30. Global Afoxolaner Chewable Tablets Revenue by Symptom (2017-2022) & (USD Million)
Table 31. Global Afoxolaner Chewable Tablets Revenue by Symptom (2023-2028) & (USD Million)
Table 32. Global Afoxolaner Chewable Tablets Price by Symptom (2017-2022) & (US$/Box)
Table 33. Global Afoxolaner Chewable Tablets Price by Symptom (2023-2028) & (US$/Box)
Table 34. North America Afoxolaner Chewable Tablets Sales by Country (2017-2022) & (Box)
Table 35. North America Afoxolaner Chewable Tablets Sales by Country (2023-2028) & (Box)
Table 36. North America Afoxolaner Chewable Tablets Revenue by Country (2017-2022) & (USD Million)
Table 37. North America Afoxolaner Chewable Tablets Revenue by Country (2023-2028) & (USD Million)
Table 38. North America Afoxolaner Chewable Tablets Sales by Purity (2017-2022) & (Box)
Table 39. North America Afoxolaner Chewable Tablets Sales by Purity (2023-2028) & (Box)
Table 40. North America Afoxolaner Chewable Tablets Sales by Symptom (2017-2022) & (Box)
Table 41. North America Afoxolaner Chewable Tablets Sales by Symptom (2023-2028) & (Box)
Table 42. Europe Afoxolaner Chewable Tablets Sales by Country (2017-2022) & (Box)
Table 43. Europe Afoxolaner Chewable Tablets Sales by Country (2023-2028) & (Box)
Table 44. Europe Afoxolaner Chewable Tablets Revenue by Country (2017-2022) & (USD Million)
Table 45. Europe Afoxolaner Chewable Tablets Revenue by Country (2023-2028) & (USD Million)
Table 46. Europe Afoxolaner Chewable Tablets Sales by Purity (2017-2022) & (Box)
Table 47. Europe Afoxolaner Chewable Tablets Sales by Purity (2023-2028) & (Box)
Table 48. Europe Afoxolaner Chewable Tablets Sales by Symptom (2017-2022) & (Box)
Table 49. Europe Afoxolaner Chewable Tablets Sales by Symptom (2023-2028) & (Box)
Table 50. Asia-Pacific Afoxolaner Chewable Tablets Sales by Region (2017-2022) & (Box)
Table 51. Asia-Pacific Afoxolaner Chewable Tablets Sales by Region (2023-2028) & (Box)
Table 52. Asia-Pacific Afoxolaner Chewable Tablets Revenue by Region (2017-2022) & (USD Million)
Table 53. Asia-Pacific Afoxolaner Chewable Tablets Revenue by Region (2023-2028) & (USD Million)
Table 54. Asia-Pacific Afoxolaner Chewable Tablets Sales by Purity (2017-2022) & (Box)
Table 55. Asia-Pacific Afoxolaner Chewable Tablets Sales by Purity (2023-2028) & (Box)
Table 56. Asia-Pacific Afoxolaner Chewable Tablets Sales by Symptom (2017-2022) & (Box)
Table 57. Asia-Pacific Afoxolaner Chewable Tablets Sales by Symptom (2023-2028) & (Box)
Table 58. South America Afoxolaner Chewable Tablets Sales by Country (2017-2022) & (Box)
Table 59. South America Afoxolaner Chewable Tablets Sales by Country (2023-2028) & (Box)
Table 60. South America Afoxolaner Chewable Tablets Revenue by Country (2017-2022) & (USD Million)
Table 61. South America Afoxolaner Chewable Tablets Revenue by Country (2023-2028) & (USD Million)
Table 62. South America Afoxolaner Chewable Tablets Sales by Purity (2017-2022) & (Box)
Table 63. South America Afoxolaner Chewable Tablets Sales by Purity (2023-2028) & (Box)
Table 64. South America Afoxolaner Chewable Tablets Sales by Symptom (2017-2022) & (Box)
Table 65. South America Afoxolaner Chewable Tablets Sales by Symptom (2023-2028) & (Box)
Table 66. Middle East & Africa Afoxolaner Chewable Tablets Sales by Region (2017-2022) & (Box)
Table 67. Middle East & Africa Afoxolaner Chewable Tablets Sales by Region (2023-2028) & (Box)
Table 68. Middle East & Africa Afoxolaner Chewable Tablets Revenue by Region (2017-2022) & (USD Million)
Table 69. Middle East & Africa Afoxolaner Chewable Tablets Revenue by Region (2023-2028) & (USD Million)
Table 70. Middle East & Africa Afoxolaner Chewable Tablets Sales by Purity (2017-2022) & (Box)
Table 71. Middle East & Africa Afoxolaner Chewable Tablets Sales by Purity (2023-2028) & (Box)
Table 72. Middle East & Africa Afoxolaner Chewable Tablets Sales by Symptom (2017-2022) & (Box)
Table 73. Middle East & Africa Afoxolaner Chewable Tablets Sales by Symptom (2023-2028) & (Box)
Table 74. Afoxolaner Chewable Tablets Raw Material
Table 75. Key Manufacturers of Afoxolaner Chewable Tablets Raw Materials
Table 76. Direct Channel Pros & Cons
Table 77. Indirect Channel Pros & Cons
Table 78. Afoxolaner Chewable Tablets Typical Distributors
Table 79. Afoxolaner Chewable Tablets Typical Customers
LIST OF FIGURES
Figure 1. Afoxolaner Chewable Tablets Picture
Figure 2. Global Afoxolaner Chewable Tablets Revenue Market Share by Purity in 2021
Figure 3. Afoxolaner Chewable Tablets
Figure 4. Afoxolaner and Milbemycin Oxime Chewable Tablets
Figure 5. Global Afoxolaner Chewable Tablets Revenue Market Share by Symptom in 2021
Figure 6. Tick Infection in Dogs
Figure 7. Gastrointestinal Nematode Infection in Dogs
Figure 8. Other
Figure 9. Global Afoxolaner Chewable Tablets Revenue, (USD Million) & (Box): 2017 & 2021 & 2028
Figure 10. Global Afoxolaner Chewable Tablets Revenue and Forecast (2017-2028) & (USD Million)
Figure 11. Global Afoxolaner Chewable Tablets Sales (2017-2028) & (Box)
Figure 12. Global Afoxolaner Chewable Tablets Price (2017-2028) & (US$/Box)
Figure 13. Global Afoxolaner Chewable Tablets Production Capacity (2017-2028) & (Box)
Figure 14. Global Afoxolaner Chewable Tablets Production Capacity by Geographic Region: 2022 VS 2028
Figure 15. Afoxolaner Chewable Tablets Market Drivers
Figure 16. Afoxolaner Chewable Tablets Market Restraints
Figure 17. Afoxolaner Chewable Tablets Market Trends
Figure 18. Global Afoxolaner Chewable Tablets Sales Market Share by Manufacturer in 2021
Figure 19. Global Afoxolaner Chewable Tablets Revenue Market Share by Manufacturer in 2021
Figure 20. Afoxolaner Chewable Tablets Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 21. Top 3 Afoxolaner Chewable Tablets Manufacturer (Revenue) Market Share in 2021
Figure 22. Top 6 Afoxolaner Chewable Tablets Manufacturer (Revenue) Market Share in 2021
Figure 23. Global Afoxolaner Chewable Tablets Sales Market Share by Region (2017-2028)
Figure 24. Global Afoxolaner Chewable Tablets Revenue Market Share by Region (2017-2028)
Figure 25. North America Afoxolaner Chewable Tablets Revenue (2017-2028) & (USD Million)
Figure 26. Europe Afoxolaner Chewable Tablets Revenue (2017-2028) & (USD Million)
Figure 27. Asia-Pacific Afoxolaner Chewable Tablets Revenue (2017-2028) & (USD Million)
Figure 28. South America Afoxolaner Chewable Tablets Revenue (2017-2028) & (USD Million)
Figure 29. Middle East & Africa Afoxolaner Chewable Tablets Revenue (2017-2028) & (USD Million)
Figure 30. Global Afoxolaner Chewable Tablets Sales Market Share by Purity (2017-2028)
Figure 31. Global Afoxolaner Chewable Tablets Revenue Market Share by Purity (2017-2028)
Figure 32. Global Afoxolaner Chewable Tablets Price by Purity (2017-2028) & (US$/Box)
Figure 33. Global Afoxolaner Chewable Tablets Sales Market Share by Symptom (2017-2028)
Figure 34. Global Afoxolaner Chewable Tablets Revenue Market Share by Symptom (2017-2028)
Figure 35. Global Afoxolaner Chewable Tablets Price by Symptom (2017-2028) & (US$/Box)
Figure 36. North America Afoxolaner Chewable Tablets Sales Market Share by Purity (2017-2028)
Figure 37. North America Afoxolaner Chewable Tablets Sales Market Share by Symptom (2017-2028)
Figure 38. North America Afoxolaner Chewable Tablets Sales Market Share by Country (2017-2028)
Figure 39. North America Afoxolaner Chewable Tablets Revenue Market Share by Country (2017-2028)
Figure 40. United States Afoxolaner Chewable Tablets Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 41. Canada Afoxolaner Chewable Tablets Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 42. Mexico Afoxolaner Chewable Tablets Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 43. Europe Afoxolaner Chewable Tablets Sales Market Share by Purity (2017-2028)
Figure 44. Europe Afoxolaner Chewable Tablets Sales Market Share by Symptom (2017-2028)
Figure 45. Europe Afoxolaner Chewable Tablets Sales Market Share by Country (2017-2028)
Figure 46. Europe Afoxolaner Chewable Tablets Revenue Market Share by Country (2017-2028)
Figure 47. Germany Afoxolaner Chewable Tablets Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 48. France Afoxolaner Chewable Tablets Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. United Kingdom Afoxolaner Chewable Tablets Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. Russia Afoxolaner Chewable Tablets Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Italy Afoxolaner Chewable Tablets Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Asia-Pacific Afoxolaner Chewable Tablets Sales Market Share by Region (2017-2028)
Figure 53. Asia-Pacific Afoxolaner Chewable Tablets Sales Market Share by Symptom (2017-2028)
Figure 54. Asia-Pacific Afoxolaner Chewable Tablets Sales Market Share by Region (2017-2028)
Figure 55. Asia-Pacific Afoxolaner Chewable Tablets Revenue Market Share by Region (2017-2028)
Figure 56. China Afoxolaner Chewable Tablets Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Japan Afoxolaner Chewable Tablets Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. Korea Afoxolaner Chewable Tablets Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. India Afoxolaner Chewable Tablets Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Southeast Asia Afoxolaner Chewable Tablets Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Australia Afoxolaner Chewable Tablets Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. South America Afoxolaner Chewable Tablets Sales Market Share by Purity (2017-2028)
Figure 63. South America Afoxolaner Chewable Tablets Sales Market Share by Symptom (2017-2028)
Figure 64. South America Afoxolaner Chewable Tablets Sales Market Share by Country (2017-2028)
Figure 65. South America Afoxolaner Chewable Tablets Revenue Market Share by Country (2017-2028)
Figure 66. Brazil Afoxolaner Chewable Tablets Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. Argentina Afoxolaner Chewable Tablets Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. Middle East & Africa Afoxolaner Chewable Tablets Sales Market Share by Purity (2017-2028)
Figure 69. Middle East & Africa Afoxolaner Chewable Tablets Sales Market Share by Symptom (2017-2028)
Figure 70. Middle East & Africa Afoxolaner Chewable Tablets Sales Market Share by Region (2017-2028)
Figure 71. Middle East & Africa Afoxolaner Chewable Tablets Revenue Market Share by Region (2017-2028)
Figure 72. Turkey Afoxolaner Chewable Tablets Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Egypt Afoxolaner Chewable Tablets Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. Saudi Arabia Afoxolaner Chewable Tablets Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. South Africa Afoxolaner Chewable Tablets Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. Manufacturing Cost Structure Analysis of Afoxolaner Chewable Tablets in 2021
Figure 77. Manufacturing Process Analysis of Afoxolaner Chewable Tablets
Figure 78. Afoxolaner Chewable Tablets Industrial Chain
Figure 79. Sales Channel: Direct Channel vs Indirect Channel
Figure 80. Methodology
Figure 81. Research Process and Data Source
Figure 1. Afoxolaner Chewable Tablets Picture
Figure 2. Global Afoxolaner Chewable Tablets Revenue Market Share by Purity in 2021
Figure 3. Afoxolaner Chewable Tablets
Figure 4. Afoxolaner and Milbemycin Oxime Chewable Tablets
Figure 5. Global Afoxolaner Chewable Tablets Revenue Market Share by Symptom in 2021
Figure 6. Tick Infection in Dogs
Figure 7. Gastrointestinal Nematode Infection in Dogs
Figure 8. Other
Figure 9. Global Afoxolaner Chewable Tablets Revenue, (USD Million) & (Box): 2017 & 2021 & 2028
Figure 10. Global Afoxolaner Chewable Tablets Revenue and Forecast (2017-2028) & (USD Million)
Figure 11. Global Afoxolaner Chewable Tablets Sales (2017-2028) & (Box)
Figure 12. Global Afoxolaner Chewable Tablets Price (2017-2028) & (US$/Box)
Figure 13. Global Afoxolaner Chewable Tablets Production Capacity (2017-2028) & (Box)
Figure 14. Global Afoxolaner Chewable Tablets Production Capacity by Geographic Region: 2022 VS 2028
Figure 15. Afoxolaner Chewable Tablets Market Drivers
Figure 16. Afoxolaner Chewable Tablets Market Restraints
Figure 17. Afoxolaner Chewable Tablets Market Trends
Figure 18. Global Afoxolaner Chewable Tablets Sales Market Share by Manufacturer in 2021
Figure 19. Global Afoxolaner Chewable Tablets Revenue Market Share by Manufacturer in 2021
Figure 20. Afoxolaner Chewable Tablets Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 21. Top 3 Afoxolaner Chewable Tablets Manufacturer (Revenue) Market Share in 2021
Figure 22. Top 6 Afoxolaner Chewable Tablets Manufacturer (Revenue) Market Share in 2021
Figure 23. Global Afoxolaner Chewable Tablets Sales Market Share by Region (2017-2028)
Figure 24. Global Afoxolaner Chewable Tablets Revenue Market Share by Region (2017-2028)
Figure 25. North America Afoxolaner Chewable Tablets Revenue (2017-2028) & (USD Million)
Figure 26. Europe Afoxolaner Chewable Tablets Revenue (2017-2028) & (USD Million)
Figure 27. Asia-Pacific Afoxolaner Chewable Tablets Revenue (2017-2028) & (USD Million)
Figure 28. South America Afoxolaner Chewable Tablets Revenue (2017-2028) & (USD Million)
Figure 29. Middle East & Africa Afoxolaner Chewable Tablets Revenue (2017-2028) & (USD Million)
Figure 30. Global Afoxolaner Chewable Tablets Sales Market Share by Purity (2017-2028)
Figure 31. Global Afoxolaner Chewable Tablets Revenue Market Share by Purity (2017-2028)
Figure 32. Global Afoxolaner Chewable Tablets Price by Purity (2017-2028) & (US$/Box)
Figure 33. Global Afoxolaner Chewable Tablets Sales Market Share by Symptom (2017-2028)
Figure 34. Global Afoxolaner Chewable Tablets Revenue Market Share by Symptom (2017-2028)
Figure 35. Global Afoxolaner Chewable Tablets Price by Symptom (2017-2028) & (US$/Box)
Figure 36. North America Afoxolaner Chewable Tablets Sales Market Share by Purity (2017-2028)
Figure 37. North America Afoxolaner Chewable Tablets Sales Market Share by Symptom (2017-2028)
Figure 38. North America Afoxolaner Chewable Tablets Sales Market Share by Country (2017-2028)
Figure 39. North America Afoxolaner Chewable Tablets Revenue Market Share by Country (2017-2028)
Figure 40. United States Afoxolaner Chewable Tablets Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 41. Canada Afoxolaner Chewable Tablets Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 42. Mexico Afoxolaner Chewable Tablets Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 43. Europe Afoxolaner Chewable Tablets Sales Market Share by Purity (2017-2028)
Figure 44. Europe Afoxolaner Chewable Tablets Sales Market Share by Symptom (2017-2028)
Figure 45. Europe Afoxolaner Chewable Tablets Sales Market Share by Country (2017-2028)
Figure 46. Europe Afoxolaner Chewable Tablets Revenue Market Share by Country (2017-2028)
Figure 47. Germany Afoxolaner Chewable Tablets Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 48. France Afoxolaner Chewable Tablets Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. United Kingdom Afoxolaner Chewable Tablets Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. Russia Afoxolaner Chewable Tablets Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Italy Afoxolaner Chewable Tablets Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Asia-Pacific Afoxolaner Chewable Tablets Sales Market Share by Region (2017-2028)
Figure 53. Asia-Pacific Afoxolaner Chewable Tablets Sales Market Share by Symptom (2017-2028)
Figure 54. Asia-Pacific Afoxolaner Chewable Tablets Sales Market Share by Region (2017-2028)
Figure 55. Asia-Pacific Afoxolaner Chewable Tablets Revenue Market Share by Region (2017-2028)
Figure 56. China Afoxolaner Chewable Tablets Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Japan Afoxolaner Chewable Tablets Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. Korea Afoxolaner Chewable Tablets Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. India Afoxolaner Chewable Tablets Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Southeast Asia Afoxolaner Chewable Tablets Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Australia Afoxolaner Chewable Tablets Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. South America Afoxolaner Chewable Tablets Sales Market Share by Purity (2017-2028)
Figure 63. South America Afoxolaner Chewable Tablets Sales Market Share by Symptom (2017-2028)
Figure 64. South America Afoxolaner Chewable Tablets Sales Market Share by Country (2017-2028)
Figure 65. South America Afoxolaner Chewable Tablets Revenue Market Share by Country (2017-2028)
Figure 66. Brazil Afoxolaner Chewable Tablets Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. Argentina Afoxolaner Chewable Tablets Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. Middle East & Africa Afoxolaner Chewable Tablets Sales Market Share by Purity (2017-2028)
Figure 69. Middle East & Africa Afoxolaner Chewable Tablets Sales Market Share by Symptom (2017-2028)
Figure 70. Middle East & Africa Afoxolaner Chewable Tablets Sales Market Share by Region (2017-2028)
Figure 71. Middle East & Africa Afoxolaner Chewable Tablets Revenue Market Share by Region (2017-2028)
Figure 72. Turkey Afoxolaner Chewable Tablets Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Egypt Afoxolaner Chewable Tablets Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. Saudi Arabia Afoxolaner Chewable Tablets Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. South Africa Afoxolaner Chewable Tablets Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. Manufacturing Cost Structure Analysis of Afoxolaner Chewable Tablets in 2021
Figure 77. Manufacturing Process Analysis of Afoxolaner Chewable Tablets
Figure 78. Afoxolaner Chewable Tablets Industrial Chain
Figure 79. Sales Channel: Direct Channel vs Indirect Channel
Figure 80. Methodology
Figure 81. Research Process and Data Source
